Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,308
archived clinical trials in
Hepatitis

Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and GS-9674 in Adults With Nonalcoholic Steatohepatitis (NASH)
A Proof of Concept, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Regimens in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Florida Research Institute
1140
mi
from
Lakewood Ranch, FL
Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and GS-9674 in Adults With Nonalcoholic Steatohepatitis (NASH)
A Proof of Concept, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Regimens in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Florida Research Institute
1140
mi
from
Lakewood Ranch, FL
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
UCSD Medical Center
1141
mi
from
San Diego, CA
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
UCSD Medical Center
1141
mi
from
San Diego, CA
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
1341
mi
from
San Francisco, CA
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
1341
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Yale University Digestive Diseases
1344
mi
from
New Haven, CT
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Yale University Digestive Diseases
1344
mi
from
New Haven, CT
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
University of Florida
1049
mi
from
Gainesville, FL
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
University of Florida
1049
mi
from
Gainesville, FL
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
University of Florida - Jacksonville
1053
mi
from
Jacksonville, FL
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
University of Florida - Jacksonville
1053
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
University Of Miami Schiff Center For Liver Diseases
1320
mi
from
Miami, FL
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
University Of Miami Schiff Center For Liver Diseases
1320
mi
from
Miami, FL
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Orlando Immunology Center
1142
mi
from
Orlando, FL
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Orlando Immunology Center
1142
mi
from
Orlando, FL
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Northwestern University
611
mi
from
Chicago, IL
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Northwestern University
611
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Indiana University Medical Center
643
mi
from
Indianapolis, IN
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Indiana University Medical Center
643
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
John Hopkins University
1149
mi
from
Lutherville, MD
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
John Hopkins University
1149
mi
from
Lutherville, MD
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
University of Michigan
808
mi
from
Ann Arbor, MI
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
University of Michigan
808
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
552
mi
from
Minneapolis, MN
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
552
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Saint Louis University
415
mi
from
Saint Louis, MO
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Saint Louis University
415
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Univ of Nebraska Med Ctr
262
mi
from
Omaha, NE
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Univ of Nebraska Med Ctr
262
mi
from
Omaha, NE
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Southwest CARE Center
475
mi
from
Santa Fe, NM
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Southwest CARE Center
475
mi
from
Santa Fe, NM
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
1286
mi
from
New York, NY
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
1286
mi
from
New York, NY
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Mountain View Medical Center
518
mi
from
Valatie, NY
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Mountain View Medical Center
518
mi
from
Valatie, NY
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
1038
mi
from
Chapel Hill, NC
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
1038
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
1052
mi
from
Durham, NC
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
1052
mi
from
Durham, NC
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati
726
mi
from
Cincinnati, OH
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati
726
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
1223
mi
from
Philadelphia, PA
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
1223
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Research Specialist of Texas
572
mi
from
Houston, TX
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Research Specialist of Texas
572
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Bon Secours St. Mary 's Hospital of Richmond (Liver Institute of Virginia)
1111
mi
from
Richmond, VA
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Bon Secours St. Mary 's Hospital of Richmond (Liver Institute of Virginia)
1111
mi
from
Richmond, VA
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Weill-Cornell Medical College
1289
mi
from
New York, NY
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Weill-Cornell Medical College
1289
mi
from
New York, NY
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Liver Wellness Center
368
mi
from
Little Rock, AR
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Liver Wellness Center
368
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Stanford University
1329
mi
from
Palo Alto, CA
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Stanford University
1329
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
UCSF/Zuckerberg San Francisco General Hospital and Trauma Center
1340
mi
from
San Francisco, CA
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
UCSF/Zuckerberg San Francisco General Hospital and Trauma Center
1340
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Internal Medicine Associates of Wellstar Atlanta Medical Center
801
mi
from
Atlanta, GA
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Internal Medicine Associates of Wellstar Atlanta Medical Center
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
1443
mi
from
Boston, MA
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Mt. Sinai Beth Israel
1225
mi
from
New York, NY
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Mt. Sinai Beth Israel
1225
mi
from
New York, NY
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
1410
mi
from
Seattle, WA
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
GI Associates & Endoscopy Center
574
mi
from
Flowood, MS
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
GI Associates & Endoscopy Center
574
mi
from
Flowood, MS
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University
1113
mi
from
Richmond, VA
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University
1113
mi
from
Richmond, VA
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
New York Langone Medical Center
1286
mi
from
New York, NY
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
New York Langone Medical Center
1286
mi
from
New York, NY
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Virginia Mason Medical Center
1410
mi
from
Seattle, WA
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Virginia Mason Medical Center
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Georgetown University
1127
mi
from
Washington,
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Georgetown University
1127
mi
from
Washington,
Click here to add this to my saved trials
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated:  12/31/1969
Howard University
1127
mi
from
Washington,
Study of Oral Treatments for Hepatitis C
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Status: Enrolling
Updated: 12/31/1969
Howard University
1127
mi
from
Washington,
Click here to add this to my saved trials
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated:  12/31/1969
Alabama Therapeutics CRS
676
mi
from
Birmingham, AL
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated: 12/31/1969
Alabama Therapeutics CRS
676
mi
from
Birmingham, AL
Click here to add this to my saved trials
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated:  12/31/1969
UCLA CARE Center CRS
1176
mi
from
Los Angeles, CA
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated: 12/31/1969
UCLA CARE Center CRS
1176
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated:  12/31/1969
Stanford AIDS Clinical Trials Unit CRS
1330
mi
from
Palo Alto, CA
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated: 12/31/1969
Stanford AIDS Clinical Trials Unit CRS
1330
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated:  12/31/1969
UCSD Antiviral Research Center CRS
1142
mi
from
San Diego, CA
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated: 12/31/1969
UCSD Antiviral Research Center CRS
1142
mi
from
San Diego, CA
Click here to add this to my saved trials
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated:  12/31/1969
Ucsf Hiv/Aids Crs
1339
mi
from
San Francisco, CA
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated: 12/31/1969
Ucsf Hiv/Aids Crs
1339
mi
from
San Francisco, CA
Click here to add this to my saved trials
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital CRS (MGH CRS)
1444
mi
from
Boston, MA
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital CRS (MGH CRS)
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated:  12/31/1969
New Jersey Medical School- Adult Clinical Research Ctr. CRS
1278
mi
from
Newark, NJ
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated: 12/31/1969
New Jersey Medical School- Adult Clinical Research Ctr. CRS
1278
mi
from
Newark, NJ
Click here to add this to my saved trials
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated:  12/31/1969
Weill Cornell Chelsea CRS
1286
mi
from
New York, NY
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Chelsea CRS
1286
mi
from
New York, NY
Click here to add this to my saved trials
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated:  12/31/1969
Columbia P&S CRS
1290
mi
from
New York, NY
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated: 12/31/1969
Columbia P&S CRS
1290
mi
from
New York, NY
Click here to add this to my saved trials
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated:  12/31/1969
Trillium Health ACTG CRS
1123
mi
from
Rochester, NY
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated: 12/31/1969
Trillium Health ACTG CRS
1123
mi
from
Rochester, NY
Click here to add this to my saved trials
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated:  12/31/1969
Univ. of Rochester ACTG CRS
1121
mi
from
Rochester, NY
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated: 12/31/1969
Univ. of Rochester ACTG CRS
1121
mi
from
Rochester, NY
Click here to add this to my saved trials
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated:  12/31/1969
Chapel Hill CRS
1039
mi
from
Chapel Hill, NC
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection
Status: Enrolling
Updated: 12/31/1969
Chapel Hill CRS
1039
mi
from
Chapel Hill, NC
Click here to add this to my saved trials